Skip to content
Screener

Enovis ENOV Total Liabilities & Equity

Total Liabilities & Equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$201.06B+4.0%
Stryker logo
StrykerSYK
$47.93B+3.5%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$873.02M+4.3%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$22.8B-0.3%
Treace Medical Concepts, Inc. logo
Treace Medical Concepts, Inc.TMCI
$181.06M-12.3%
ESAB logo
ESABESAB
$6.56B+48.1%

Other financials

Income statement

See full
Revenue$582.8M+3.2%
Gross profit$359.2M+7.3%
Operating income$17.4M+204%
Net income-$1.2M+96.8%
EPS (diluted)-$0.02+96.9%

Balance sheet

See full
Cash & equivalents$12.6M-71.5%
Total debt$1.3B-6.4%
Total equity$1.5B-42.7%
Total assets$3.8B-25.0%

Cash flow

See full
Operating cash flow$75.0M+57.1%
CapEx$43.9M-1.1%
Free cash flow$31.1M

Valuation

See full
Market cap$1.53B-5.5%
Enterprise value$2.83B-4.9%
P/S0.7×-0.1×

Profitability

See full
Gross margin61.1%+3.5pp
Operating margin-45.1%+19.4pp
Net margin-48%+17.7pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-54.3%+672pp
Debt / equity0.9×+0.3×
Current ratio-0.3×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Enovis’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001420800-26-000035
Line itemJuly 3, 2026December 31, 2025
Common stock, $0.001 par value; 133,333,333 shares authorized; 57,665,074 and 57,194,781 shares issued and outstanding as of July 3, 2026 and December 31, 2025, respectively5857
Additional paid-in capital3,065,6673,048,414
Accumulated deficit(1,477,417)(1,467,463)
Accumulated other comprehensive loss(111,241)(91,363)
Total Enovis Corporation equity1,477,0671,489,645
Noncontrolling interest2,0982,257
Total equity1,479,1651,491,902
Total liabilities and equity$3,766,126$3,834,737

Item 1. Financial Statements

FAQ

What is Enovis's total liabilities & equity?
Enovis (ENOV) reported total liabilities & equity of $3.77B in Q2 2026.
How has Enovis's total liabilities & equity changed year-over-year?
Enovis's total liabilities & equity decreased by 25.0% year-over-year, from $5.02B to $3.77B.
What is the long-term trend for Enovis's total liabilities & equity?
Over 5 years (2020 to 2025), Enovis's total liabilities & equity has grown at a -12.2% compound annual growth rate (CAGR), from $7.35B to $3.83B.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Enovis's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude